Watch the full RS Oncology symposium presentation from IMIG 2023
Our Chief Science Officer, Brian Cunniff, presented "Characterization of Immune Cell Phenotypes in Patient Derived Malignant Pleural Effusion Treated with Thiostrepton"
RS Oncology successfully presented their first-in-human clinical trial poster at ESMO Congress 2022.